Basit öğe kaydını göster

Favorable Long-Term Outcome in Male Breast Cancer

dc.contributor.authorDinccag, Ahmet Said
dc.contributor.authorOzmen, Vahit
dc.contributor.authorCabioglu, Neslihan
dc.contributor.authorMuslumanoglu, Mahmut
dc.contributor.authorIgci, Abdullah
dc.contributor.authorOzkurt, Enver
dc.contributor.authorTukenmez, Mustafa
dc.contributor.authorYilmaz, Ravza Sümeyye
dc.date.accessioned2021-03-06T21:37:08Z
dc.date.available2021-03-06T21:37:08Z
dc.identifier.citationOzkurt E., Tukenmez M., Yilmaz R. S. , Cabioglu N., Muslumanoglu M., Dinccag A. S. , Igci A., Ozmen V., "Favorable Long-Term Outcome in Male Breast Cancer", EUROPEAN JOURNAL OF BREAST HEALTH, cilt.14, ss.180-185, 2018
dc.identifier.othervv_1032021
dc.identifier.otherav_ff8723fb-4d1a-4eb1-b29a-2d292389adeb
dc.identifier.urihttp://hdl.handle.net/20.500.12627/167048
dc.identifier.urihttps://doi.org/10.5152/ejbh.2018.3946
dc.description.abstractObjective: Male breast cancer (MBC) is a rare type of cancer in the breast cancer series and in the male population. Data is usually extrapolated from female breast cancer (FBC) studies. We aim to study the clinicopathological characteristics and outcome of MBC patients at our institution and we aim to emphasize the differences compared with FBC.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.subjectOnkoloji
dc.titleFavorable Long-Term Outcome in Male Breast Cancer
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF BREAST HEALTH
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume14
dc.identifier.startpage180
dc.identifier.endpage185
dc.contributor.firstauthorID2502861


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster